Attention-deficit/hyperactivity disorder

The SAGE Handbook of Developmental Disorders

Volumn , Issue , 2011, Pages 263-286

  Wilens, Timothy Edwin ^a,b   Spencer, Thomas J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84952305787     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4135/9781446201107.n14     Document Type: Chapter

References (148)

1. Abikoff, H.'Cognitive training in ADHD children; Less to it than meets the eye', Journal of Learning Disabilities, 24 205-209. (1991) doi:10.1177/002221949102400404 http://dx.doi.org/10.1177/002221949102400404
2. Abikoff, H., Hechtman, L. et al. 'Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment', Journal of the American Academy of Child and Adolescent Psychiatry, 43 (7) 802-811. (2004) doi:10.1097/01.chi.0000128791.10014.ac http://dx.doi.org/10.1097/01.chi.0000128791.10014.ac
3. Adler, L., Cohen, J.'Diagnosis and evaluation of adults with ADHD', Psychiatric Clinics of North America, 27 187-201. (2004) doi:10.1016/j.psc.2003.12.003 http://dx.doi.org/10.1016/j.psc.2003.12.003
4. American Academy of Child and Adolescent Psychiatry 'Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults', Journal of the American Academy of Child and Adolescent Psychiatry, 41 (2 Suppl) 26S-49S. (2002) doi:10.1097/00004583-200202001-00003 http://dx.doi.org/10.1097/00004583-200202001-00003
5. American Academy of Pediatrics 'Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder', Pediatrics, 108 (4) 1033-1044. (2001) doi:10.1542/peds.108.4.1033 http://dx.doi.org/10.1542/peds.108.4.1033
6. Anderson, J. C., Williams, S. et al. 'DSM-III disorders in preadolescent children: prevalence in a large sample from the general population', Archives of General Psychiatry, 44 69-76. (1987) doi:10.1001/archpsyc.1987.01800130081010 http://dx.doi.org/10.1001/archpsyc.1987.01800130081010
7. Angold, A., Costello, E. J.'Depressive comorbidity in children and adolescents: empirical, theoretical and methodological issues', American Journal of Psychiatry, 150 (12) 1779-1791. (1993)
8. Anon 'Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder', Pediatrics, 108 (4) 1033-1044. (2001) doi:10.1542/peds.108.4.1033 http://dx.doi.org/10.1542/peds.108.4.1033
9. APA (1994) Diagnostic and Statistical Manual of Mental Disorders IV. Washington, DC: American Psychiatric Association Press.
10. Barkley, R.'Major life activity and health outcomes associated with attention-deficit hyperactivity disorder', Journal of Clinical Psychiatry, 63 (Supp 12) 10-15. (2002)
11. Barkley, R. (2005) Attention-Deficit/Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guilford Press.
12. Barkley, R., Biederman, J.'The case against a specific age of onset criterion for attention deficit hyperactivity disorder', American Journal of Psychiatry, 36 (9) 1204-1210. (1997)
13. Barkley, R. A.'Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD', Psychological Bulletin, 121 (1) 65-94. (1997) doi:10.1037/0033-2909.121.1.65 http://dx.doi.org/10.1037/0033-2909.121.1.65
14. Barkley, R. A., Fischer, M. et al. 'The adolescent outcome of hyperactive children diagnosed by research criteria: I. an 8-year prospective followup study', Journal of the American Academy of Child and Adolescent Psychiatry, 29 546-557. (1990) doi:10.1097/00004583-199007000-00007 http://dx.doi.org/10.1097/00004583-199007000-00007
15. Barkley, R. A., McMurray, M. B. et al. 'Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation', Pediatrics 86 (2) 184-192. (1990)
16. Barkley, R. A., Murphy, K. R. et al. 'Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning', Journal of the International Neuropsychological Society, 8 (5) 655-672. (2002) doi:10.1017/S1355617702801345 http://dx.doi.org/10.1017/S1355617702801345
17. Biederman, J., Faraone, S. et al. (1996) 'Comorbidity in outcome of attention-deficit hyperactivity disorder', in L.Hechtman (ed), Do They Grow Out of It? Long Term Outcome of Childhood Disorders Washington, DC: American Psychiatric Presspp. 39-76.
18. Biederman, J., Faraone, S. et al. 'Age dependent decline of ADHD symptoms revisited: impact of remission definition and symptom subtype', American Journal of Psychiatry, 157 816-817. (2000) doi:10.1176/appi.ajp.157.5.816 http://dx.doi.org/10.1176/appi.ajp.157.5.816
19. Biederman, J., Faraone, S. V. et al. 'Gender effects of attention deficit hyperactivity disorder in adults, revisited', Biological Psychiatry, 55 (7) 692-700. (2004) doi:10.1016/j.biopsych.2003.12.003 http://dx.doi.org/10.1016/j.biopsych.2003.12.003
20. Biederman, J., Melmed, R. D. et al. 'A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder', Pediatrics 121 (1) e73-84. (2008) doi:10.1542/peds.2006-3695 http://dx.doi.org/10.1542/peds.2006-3695
21. Biederman, J., Monuteaux, M. et al. 'Impact of executive function deficits and ADHD on academic outcomes in children', Journal of Consulting and Clinical Psychology, 72 (5) 757-766. (2004) doi:10.1037/0022-006X.72.5.757 http://dx.doi.org/10.1037/0022-006X.72.5.757
22. Biederman, J., Monuteaux, M. et al. 'Young adult outcome of attention deficit hyperactivity disorder: a controlled 10 year follow-up study', Psychological Medicine, 36 167-179. (2006a)doi:10.1017/S0033291705006410 http://dx.doi.org/10.1017/S0033291705006410
23. Biederman, J., Monuteaux, M. et al. 'Is cigarette smoking a gateway drug to subsequent alcohol and illicit drug use disorders? A controlled study of youths with and without ADHD', Biological Psychiatry, 59 258-264. (2006b). doi:10.1016/j.biopsych.2005.07.009 http://dx.doi.org/10.1016/j.biopsych.2005.07.009
24. Biederman, J., Monuteaux, M. C. et al. 'Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study', The American Journal of Psychiatry, 165 (5) 597-603. (2008) doi:10.1176/appi.ajp.2007.07091486 http://dx.doi.org/10.1176/appi.ajp.2007.07091486
25. Biederman, J., Newcorn, J. et al. 'Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders', American Journal of Psychiatry, 148 564-577. (1991)
26. Biederman, J., Swanson, J. et al. 'Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study', Pediatrics 116 e777-784. (2005) doi:10.1542/peds.2005-0617 http://dx.doi.org/10.1542/peds.2005-0617
27. Biederman, J., Wilens, T. et al. 'Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder: effects of ADHD and psychiatric comorbidity', American Journal of Psychiatry, 152 (11) 1652-1658. (1995).
28. Bird, H. R., Gould, M. S. et al. 'Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years', Journal of the American Academy of Child and Adolescent Psychiatry, 32 (2) 361-368. (1993) doi:10.1097/00004583-199303000-00018 http://dx.doi.org/10.1097/00004583-199303000-00018
29. Bush, G., Frazier, J. A. et al. 'Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by f MRI and the Counting Stroop', Biological Psychiatry, 45 (12) 1542-1552. (1999) doi:10.1016/S0006-3223(99)00083-9 http://dx.doi.org/10.1016/S0006-3223%2899%2900083-9
30. Bush G, Spencer TJ, Holmes J, et al. 'Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task' Arch Gen Psychiatry. Jan 2008; 65 (1) 102-114. (2008) doi:10.1001/archgenpsychiatry.2007.16 http://dx.doi.org/10.1001/archgenpsychiatry.2007.16
31. Bukstein OG.Clinical practice guidelines for attention-deficit/hyperactivity disorder: a review Postgrad Med. Sep; 122 (5) 69-77. doi:10.3810/pgm.2010.09.2203 http://dx.doi.org/10.3810/pgm.2010.09.2203
32. Casey, B. J., Durston S.'From behavior to cognition to the brain and back: what have we learned from functional imaging studies of attention deficit hyperactivity disorder?' The American Journal of Psychiatry, 163 (6) 957-960. (2006) doi:10.1176/appi.ajp.163.6.957 http://dx.doi.org/10.1176/appi.ajp.163.6.957
33. Castellanos, F. X., Giedd, J. N. et al. 'Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose', Journal of the American Academy of Child and Adolescent Psychiatry, 36 (5) 589-596. (1997) doi:10.1097/00004583-199705000-00008 http://dx.doi.org/10.1097/00004583-199705000-00008
34. Castellanos, F. X., Lee, P. P. et al. 'Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder', The Journal of the American Medical Association, 288 (14) 1740-1748. (2002) doi:10.1001/jama.288.14.1740 http://dx.doi.org/10.1001/jama.288.14.1740
35. Centers for Disease Control and Prevention (CDC) 'Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States, 2003', Morbidity and Mortality Weekly Report, 54 842-847. (2005)
36. Chronis, A. M., Jones, H. A. et al. 'Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder', Clinical Psychology Review, 26 (4) 486-502. (2006) doi:10.1016/j.cpr.2006.01.002 http://dx.doi.org/10.1016/j.cpr.2006.01.002
37. Conners, C. K., Casat, C. D. et al. 'Bupropion hydrochloride in attention deficit disorder with hyperactivity', Journal of the American Academy of Child and Adolescent Psychiatry, 35 (10) 1314-1321. (1996) doi:10.1097/00004583-199610000-00018 http://dx.doi.org/10.1097/00004583-199610000-00018
38. Connor, D. F., Fletcher, K. E. et al. 'A metaanalysis of clonidine for symptoms of attention-deficit hyperactivity disorder', Journal of the American Academy of Child and Adolescent Psychiatry, 38 (12) 1551-1559. (1999) doi:10.1097/00004583-199912000-00017 http://dx.doi.org/10.1097/00004583-199912000-00017
39. Cummings, J. L.'Frontal-subcortical circuits and human behavior', Arch Neurol, 50 (8) 873-880. (1993) doi:10.1001/archneur.1993.00540080076020 http://dx.doi.org/10.1001/archneur.1993.00540080076020
40. Daviss, W. B., Bentivoglio, P. et al. 'Bupropion SR in adolescents with combined attention-deficit/hyperactivity disorder and depression', Journal of the American Academy of Child and Adolescent Psychiatry, 40 307-314. (2001) doi:10.1097/00004583-200103000-00010 http://dx.doi.org/10.1097/00004583-200103000-00010
41. de Zeeuw, P., Aarnoudse-Moens, C. et al. 'Inhibitory performance, response speed, intraindividual variability, and response accuracy in ADHD', Journal of the American Academy of Child and Adolescent Psychiatry, 47 (7) 808-816. (2008) doi:10.1097/CHI.0b013e318172eee9 http://dx.doi.org/10.1097/CHI.0b013e318172eee9
42. Epstein, J. N., Casey, B. J. et al. 'ADHD-and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD', Journal of Child Psychology and Psychiatry, 48 (9) 899-913. (2007). doi:10.1111/j.1469-7610.2007.01761.x http://dx.doi.org/10.1111/j.1469-7610.2007.01761.x
43. Faraone, S., Biederman, J.'Genetics of attention-deficit hyperactivity disorder', Child and Adolescent Psychiatric Clinics of North America, 3 (2) 285-302. (1994)
44. Faraone, S. V., Biederman, J. et al. 'Is comorbidity with ADHD a marker for juvenile onset mania?' Journal of the American Academy of Child and Adolescent Psychiatry, 36 (8) 1046-1055. (1997) doi:10.1097/00004583-199708000-00012 http://dx.doi.org/10.1097/00004583-199708000-00012
45. Faraone, S. V., Doyle, A. E.'The nature and heritability of attention-deficit/hyperactivity disorder' Child and Adolescent Psychiatric Clinics of North America 10 (2) 299-316, (2001) viii-ix.
46. Faraone S. V., Mick E.Molecular Genetics of Attention Deficit Hyperactivity Disorder Psychiatry Clinics of North America; 33 (1) 159-180. (2010) doi:10.1016/j.psc.2009.12.004 http://dx.doi.org/10.1016/j.psc.2009.12.004
47. Faraone, S. V., Biederman, J. et al. 'Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?', American Journal of Psychiatry, 163 (10) 1720-1729. (2006) doi:10.1176/appi.ajp.163.10.1720 http://dx.doi.org/10.1176/appi.ajp.163.10.1720
48. Findling, R. L., Short, E. J. et al. 'Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder', Journal of the American Academy of Child and Adolescent Psychiatry, 46 (11) 1445-1453. (2007) doi:10.1097/chi.0b013e31814b8d3b http://dx.doi.org/10.1097/chi.0b013e31814b8d3b
49. Gadow, K., Sverd, J. et al. 'Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder', Archives of General Psychiatry, 56 (4) 330-336. (1999) doi:10.1001/archpsyc.56.4.330 http://dx.doi.org/10.1001/archpsyc.56.4.330
50. Gammon, G. D., Brown, T. E.'Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder', Journal of Child and Adolescent Psychopharmacology, 3 (1) 1-10. (1993) doi:10.1089/cap.1993.3.1 http://dx.doi.org/10.1089/cap.1993.3.1
51. Geller, B., Zimerman, B. et al. 'Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder', Journal of Child and Adolescent Psychopharmacology, 10 (3) 157-164. (2000) doi:10.1089/10445460050167269 http://dx.doi.org/10.1089/10445460050167269
52. Geller, D., Donnelly, C. et al. 'Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder', Journal of the American Academy of Child and Adolescent Psychiatry, 46 (9) 1119-1127. (2007) doi:10.1097/chi.0b013e3180ca8385 http://dx.doi.org/10.1097/chi.0b013e3180ca8385
53. Gittelman, R., Mannuzza, S. et al. 'Hyperactive boys almost grown up. I. Psychiatric status', Archives of General Psychiatry, 42 937-947. (1985) doi:10.1001/archpsyc.1985.01790330017002 http://dx.doi.org/10.1001/archpsyc.1985.01790330017002
54. Goodman, R., Stevenson, J.'A twin study of hyperactivity-I. An examination of hyperactivity scores and categories derived from Rutter teacher and parent questionnaires', Journal of Child Psychology and Psychiatry, 30 (B) 671-689. (1989) doi:10.1111/j.1469-7610.1989.tb00781.x http://dx.doi.org/10.1111/j.1469-7610.1989.tb00781.x
55. Greenhill, L., Osman, B. (1999) Ritalin: Theory and Practice. New York: Mary Ann Liebert.
56. Greenhill, L., Kollins, S. et al. 'Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD', Journal of the American Academy of Child and Adolescent Psychiatry, 45 (11) 1284-1293. (2006) doi:10.1097/01.chi.0000235077.32661.61 http://dx.doi.org/10.1097/01.chi.0000235077.32661.61
57. Greenhill, L. L., Pliszka, S. et al. 'Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults', Journal of the American Academy of Child and Adolescent Psychiatry, 41 (2 Suppl) 26S-49S. (2002) doi:10.1097/00004583-200202001-00003 http://dx.doi.org/10.1097/00004583-200202001-00003
58. Gutgesell, H., Atkins, D. et al. 'Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young', American Heart Association Circulation, 99 (7) 979-982. (1999)
59. Hammerness, P., Georgiopoulos, A. et al. 'An open study of adjunct OROS-methyophenidate in children who are atomoxetine partial responders: II. Tolerability and Pharmacoinetics', J Child Adolesc Psychopharmacol, 19 (5) 493-499. (2009) doi:10.1089/cap.2008.0126 http://dx.doi.org/10.1089/cap.2008.0126
60. Hart, E. L., Lahey, B. B. et al. 'Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study', Journal of Abnormal Child Psychology, 23 (6) 729-749. (1995) doi:10.1007/BF01447474 http://dx.doi.org/10.1007/BF01447474
61. Hazell, P. L., Stuart, J. E.'A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children', Journal of the American Academy of Child and Adolescent Psychiatry, 42 (8) 886-894. (2003) doi:10.1097/01.CHI.0000046908.27264.00 http://dx.doi.org/10.1097/01.CHI.0000046908.27264.00
62. Hechtman, L., Weiss, G.'Controlled prospective fifteen year follow-up of hyperactives as adults: nonmedical drug and alcohol use and anti-social behaviour', Canadian Journal of Psychiatry, 31 557-567. (1986)
63. Hechtman, L., Abikoff, H. et al. 'Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment', Journal of the American Academy of Child and Adolescent Psychiatry, 43 (7) 812-819. (2004) doi:10.1097/01.chi.0000128796.84202.eb http://dx.doi.org/10.1097/01.chi.0000128796.84202.eb
64. Hervey, A. S., Epstein, J. et al. 'The neuropsychology of adults with attention deficit hyperactivity disorder: a meta-analytic review', Neuropsychology, 18 (3) 485-503. (2004) doi:10.1037/0894-4105.18.3.485 http://dx.doi.org/10.1037/0894-4105.18.3.485
65. Hunt, R. D., Minderaa, R. B. et al. 'Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial', Journal of the American Academy of Child and Adolescent Psychiatry, 24 617-629. (1985) doi:10.1016/S0002-7138(09)60065-0 http://dx.doi.org/10.1016/S0002-7138%2809%2960065-0
66. Jensen, P. S., Shervette, R. E. et al. 'Anxiety and depressive disorders in attention deficit hyperactivity disorder with hyperactivity: new findings', American Journal of Psychiatry, 150 1203-1209. (1993)
67. Kessler, R. C., Adler, L. et al. 'The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population', Psychological Medicine, 35 (2) 245-256. (2005) doi:10.1017/S0033291704002892 http://dx.doi.org/10.1017/S0033291704002892
68. Kessler, R. C., Adler, L. et al. 'The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication', American Journal of Psychiatry, 163 (4) 716-723. (2006) doi:10.1176/appi.ajp.163.4.716 http://dx.doi.org/10.1176/appi.ajp.163.4.716
69. Kramer, J. R., Loney, J. et al. 'Predictors of adult height and weight in boys treated with methylphenidate for childhood behavior problems', Journal of the American Academy of Child and Adolescent Psychiatry, 39 (4) 517-524. (2000) doi:10.1097/00004583-200004000-00022 http://dx.doi.org/10.1097/00004583-200004000-00022
70. Kurlan, R.'Methylphenidate to treat ADHD is not contraindicated in children with tics', Movement Disorders 17 (1) 5-6. (2002) doi:10.1002/mds.10094 http://dx.doi.org/10.1002/mds.10094
71. Lahey, B. B., Pelham, W. E. et al. 'Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school', Archives of General Psychiatry, 62 (8) 896-902. (2005) doi:10.1001/archpsyc.62.8.896 http://dx.doi.org/10.1001/archpsyc.62.8.896
72. Levin, F. R., Evans, S. M.'Diagnostic and treatment issues in comorbid substance abuse and adult attention-deficit hyperactivity disorder', Psychiatric Annals, 31 (5) 303-312. (2001)
73. Levy, F., Hay, D. et al. 'Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study', Journal of the American Academy of Child and Adolescent Psychiatry, 36 (6) 737-744. (1997) doi:10.1097/00004583-199706000-00009 http://dx.doi.org/10.1097/00004583-199706000-00009
74. Loney, J., Kramer, J. et al. (1981) 'The hyperactive child grows up: predictors of symptoms, delinquency and achievement at follow-up', in K. D.Gadow, J.Loney (eds), Psychosocial Aspects of Drug Treatment for Hyperactivity Boulder, CO: Westview Presspp. 381-416.
75. McCabe, S. E., Knight, J. R. et al. 'Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey', Addiction, 99 (1) 96-106. (2005) doi:10.1111/j.1360-0443.2005.00944.x http://dx.doi.org/10.1111/j.1360-0443.2005.00944.x
76. McDermott, S. P., Wilens, T. E. (2000) 'Cognitive therapy for adults with ADHD', in T.Brown (ed.), Subtypes of Attention Deficit Disorders in Children, Adolescents, and Adults Washington, DC: American Psychiatric Presspp. 569-606.
77. McGuffin, P., Riley, B. et al. 'Toward behavioral genomics', Science 291 1232-1249. (2001) doi:10.1126/science.1057264 http://dx.doi.org/10.1126/science.1057264
78. Makris, N., Biederman, J. et al. 'Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder', Cerebral Cortex, 17 (6) 1364-1375. (2007) doi:10.1093/cercor/bhl047 http://dx.doi.org/10.1093/cercor/bhl047
79. Mannuzza, S., Klein, R. G. et al. 'Adult outcome of hyperactive boys: educational achievement, occupational rank and psychiatric status', Archives of General Psychiatry, 50 565-576. (1993) doi:10.1001/archpsyc.1993.01820190067007 http://dx.doi.org/10.1001/archpsyc.1993.01820190067007
80. Mannuzza, S., Klein, R. G. et al. 'Young adult outcome of children with "situational" hyperactivity: a prospective, controlled follow-up study', Journal of Abnormal Child Psychology, 30 (2) 191-198. (2002) doi:10.1023/A:1014761401202 http://dx.doi.org/10.1023/A:1014761401202
81. Martinussen, R., Hayden, J. et al. 'A metaanalysis of working memory impairments in children with attention-deficit/hyperactivity disorder', Journal of the American Academy of Child and Adolescent Psychiatry, 44 (4) 377-384. (2005) doi:10.1097/01.chi.0000153228.72591.73 http://dx.doi.org/10.1097/01.chi.0000153228.72591.73
82. Michelson, D., Allen, A. J. et al. 'Once-daily atomoxetine treatment for children and adolescents with ADHD: a randomized, placebo-controlled study', American Journal of Psychiatry, 159 1896-1901. (2002) doi:10.1176/appi.ajp.159.11.1896 http://dx.doi.org/10.1176/appi.ajp.159.11.1896
83. Michelson, D., Buitelaar, J. K. et al. 'Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study', Journal of the American Academy of Child and Adolescent Psychiatry, 43 (7) 896-904. (2004) doi:10.1097/01.chi.0000125089.35109.81 http://dx.doi.org/10.1097/01.chi.0000125089.35109.81
84. Michelson, D., Faries, D. et al. 'Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study', Pediatrics, 108 (5) E83. (2001) doi:10.1542/peds.108.5.e83 http://dx.doi.org/10.1542/peds.108.5.e83
85. Mick, E., Faraone, S. V. et al. 'The course and outcome of ADHD', Primary Psychiatry, 11 (7) 42-48. (2004)
86. Milberger, S., Biederman, J. et al. 'Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms', American Journal of Psychiatry, 152 (12) 1793-1799. (1995)
87. Millstein, R. B., Wilens, T. E. et al. 'Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD', Journal of Attention Disorders, 2 (3) 159-166. (1997) doi:10.1177/108705479700200302 http://dx.doi.org/10.1177/108705479700200302
88. MTA Cooperative Group 'A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD [see comments]', Archives of General Psychiatry, 56 (12) 1073-1086. (1999a)doi:10.1001/archpsyc.56.12.1073 http://dx.doi.org/10.1001/archpsyc.56.12.1073
89. MTA Cooperative Group 'Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder', Archives of General Psychiatry, (12) 1088-1096. 56 (1999b)doi:10.1001/archpsyc.56.12.1088 http://dx.doi.org/10.1001/archpsyc.56.12.1088
90. MTA Cooperative Group 'A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD', Archives of General Psychiatry, 56 (12) 1073-1086. (1999c)doi:10.1001/archpsyc.56.12.1073 http://dx.doi.org/10.1001/archpsyc.56.12.1073
91. MTA Cooperative Group 'National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment', Pediatrics 113 762-769. (2004) doi:10.1542/peds.113.4.762 http://dx.doi.org/10.1542/peds.113.4.762
92. Murphy, P., Schachar, R.'Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults', American Journal of Psychiatry, 157 (7) 1156-1159. (2000) doi:10.1176/appi.ajp.157.7.1156 http://dx.doi.org/10.1176/appi.ajp.157.7.1156
93. Newcorn, J. H., Spencer, T. J. et al. 'Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder', Journal of the American Academy of Child and Adolescent Psychiatry, 44 (3) 240-248. (2005) doi:10.1097/00004583-200503000-00008 http://dx.doi.org/10.1097/00004583-200503000-00008
94. Palumbo, D. R., Sallee, F. R. et al. 'Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes', Journal of the American Academy of Child and Adolescent Psychiatry, 47 (2) 180-188. (2008) doi:10.1097/chi.0b013e31815d9af7 http://dx.doi.org/10.1097/chi.0b013e31815d9af7
95. Parasrampuria, D. A., Schoedel, K. A. et al. 'Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users', Journal of Clinical Psychopharmacology, 27 (5) 459-467. (2007) doi:10.1097/jcp.0b013e3181515205 http://dx.doi.org/10.1097/jcp.0b013e3181515205
96. Pelham, W., Wheeler, T. et al. 'Empirically supported psychosocial treatments for attention deficit hyperactivity disorder', Journal of Clinical Child Psychology, 27 (2) 190-205. (1998) doi:10.1207/s15374424jccp2702_6 http://dx.doi.org/10.1207/s15374424jccp2702_6
97. Perrin, J. M., Friedman, R. A. et al. 'Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder', Pediatrics, 122 (2) 451-453. (2008) doi:10.1542/peds.2008-1573 http://dx.doi.org/10.1542/peds.2008-1573
98. Polanczyk, G., de Lima, M. S. et al. 'The worldwide prevalence of ADHD: a systematic review and metaregression analysis', American Journal of Psychiatry, 164 (6) 942-948. (2007) doi:10.1176/appi.ajp.164.6.942 http://dx.doi.org/10.1176/appi.ajp.164.6.942
99. Prince, J., Wilens, T. et al. 'Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases', Journal of the American Academy of Child and Adolescent Psychiatry, 35 (5) 599-605. (1996) doi:10.1097/00004583-199605000-00014 http://dx.doi.org/10.1097/00004583-199605000-00014
100. Prince, J. B., Wilens, T. E. et al. 'A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder', Journal of Child and Adolescent Psychopharmacology, 10 (3) 193-204. (2000) doi:10.1089/10445460050167304 http://dx.doi.org/10.1089/10445460050167304
101. Rappley, M. D., Moore, J. W. et al. 'ADHD drugs and cardiovascular risk', New England Journal of Medicine, 354 (21) 2296-2298. (2006) author reply 2296-2298.doi:10.1056/NEJMc061187 http://dx.doi.org/10.1056/NEJMc061187
102. Reimherr, F. W., Hedges, D. W. et al. (1995) 'An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder, 35th, Annual Meeting New Clinical Drug Evaluation Unit Program, Orlando, Florida.
103. Safer, D., Allen, R. et al. 'Depression of growth in hyperactive children on stimulant drugs', New England Journal of Medicine, 287 (5) 217-220. (1972) doi:10.1056/NEJM197208032870503 http://dx.doi.org/10.1056/NEJM197208032870503
104. Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial Aug 25; JAMA. 304 (8) 875-880. 2010doi:10.1001/jama.2010.1192 http://dx.doi.org/10.1001/jama.2010.1192
105. Sandra Kooij, J. J., Marije Boonstra, A. et al. 'Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients', Journal of Attention Disorders, 11 (4) 445-458. (2008) doi:10.1177/1087054707299367 http://dx.doi.org/10.1177/1087054707299367
106. Seidman, L., Doyle, A. et al. 'Neuropsychological functioning in adults with attention-deficit/hyperactivity disorder', Psychiatric Clinics of North America, 27 261-282. (2004) doi:10.1016/j.psc.2003.12.005 http://dx.doi.org/10.1016/j.psc.2003.12.005
107. Seidman, L. J.'Neuropsychological functioning in people with ADHD across the lifespan', Clinical Psychology Review, 26 (4) 466-485. (2006) doi:10.1016/j.cpr.2006.01.004 http://dx.doi.org/10.1016/j.cpr.2006.01.004
108. Seidman, L. J., Valera, E. M. et al. 'Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyper-activity disorder identified by magnetic resonance imaging', Biological Psychiatry, 60 (10) 1071-1080. (2006) doi:10.1016/j.biopsych.2006.04.031 http://dx.doi.org/10.1016/j.biopsych.2006.04.031
109. Sergeant, J. A., Geurts, H. et al. 'How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder?', Behavioural Brain Research, 130 (1-2) 3-28. (2002) doi:10.1016/S0166-4328(01)00430-2 http://dx.doi.org/10.1016/S0166-4328%2801%2900430-2
110. Shaw, P., Eckstrand, K. et al. 'Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation', Proceedings of the National Academy of Sciences, 104 (49) 19649-19654. (2007) doi:10.1073/pnas.0707741104 http://dx.doi.org/10.1073/pnas.0707741104
111. Solanto MV, Marks DJ, Wasserstein J, et al. Efficacy of Meta-Cognitive Therapy for Adult ADHD Am J Psychiatry. Aug; 167 (8) 958-968. 2010doi:10.1176/appi.ajp.2009.09081123 http://dx.doi.org/10.1176/appi.ajp.2009.09081123
112. Sonuga-Barke, E., Dalen, L. et al. 'Do executive deficits and delay aversion make independent contributions to preschool attention-deficit/hyperactivity disorder symptoms', Journal of the American Academy of Child and Adolescent Psychiatry, 42 (11) 1335-1342. (2003) doi:10.1097/01.chi.0000087564.34977.21 http://dx.doi.org/10.1097/01.chi.0000087564.34977.21
113. Sonuga-Barke, E., Daley, D. et al. 'Parent-based therapies for preschool ADHD; a randomized, controlled trial with a community sample', Journal of the American Academy of Child and Adolescent Psychiatry, 40 (4) 402-408. (2001) doi:10.1097/00004583-200104000-00008 http://dx.doi.org/10.1097/00004583-200104000-00008
114. Sonuga-Barke, E., Thompson, M. et al. 'Nonpharmacological interventions for preschoolers with ADHD: the case for specialized parent training', Infants & Young Children, 19 (2) 142-153. (2006) doi:10.1097/00001163-200604000-00007 http://dx.doi.org/10.1097/00001163-200604000-00007
115. Sonuga-Barke, E. J.'The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics', Neuroscience & Biobehavioral Reviews, 27 (7) 593-604. (2003) doi:10.1016/j.neubiorev.2003.08.005 http://dx.doi.org/10.1016/j.neubiorev.2003.08.005
116. Spencer, T., Biederman, J. et al. 'Growth deficits in ADHD children', Pediatrics, 102 (Suppl 2) 501-506. (1998a)
117. Spencer J., Biederman, J. et al. (1998b). 'Pharmacotherapy of attention-deficit/hyperactivity disorder: a life span perspective', in L.Dickstein, M.Riba, & J.Oldham (eds), Review of Psychiatry. Washington, DC: American Psychiatric Press, 16: IV-87-IV-127.
118. Spencer, T., Biederman, J. et al. 'A PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short and long-acting orally administered formulations of methylphenidate in adults', American Journal of Psychiatry, 163 (3) 387-395. (2006) doi:10.1176/appi.ajp.163.3.387 http://dx.doi.org/10.1176/appi.ajp.163.3.387
119. Spencer, T., Wilens, T. E. et al. 'A double blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder', Archives of General Psychiatry, 52 434-443. (1995) doi:10.1001/archpsyc.1995.03950180020004 http://dx.doi.org/10.1001/archpsyc.1995.03950180020004
120. Stein, M. A., Sandoval, R. et al. 'Psychometric characteristics of the Wender Utah Rating Scale (WURS) reliability and factor structure for men and women', Psychopharmacology Bulletin, 31 423-431. (1995)
121. Swanson, J., Greenhill, L. et al. 'Stimulant-related reductions of growth rates in the PATS', Journal of the American Academy of Child and Adolescent Psychiatry, 45 (11) 1304-1313. (2006) doi:10.1097/01.chi.0000235075.25038.5a http://dx.doi.org/10.1097/01.chi.0000235075.25038.5a
122. Swanson, J. M., Kraemer, H. C. et al. 'Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment', Journal of the American Academy of Child and Adolescent Psychiatry, 40 (2) 168-179. (2001) doi:10.1097/00004583-200102000-00011 http://dx.doi.org/10.1097/00004583-200102000-00011
123. Swanson, J., Lerner, M. et al. 'Development of a new once-a-day formulation of methylphenidate for the treatment of ADHD: proof of concept and proof of product studies', Archives of General Psychiatry, 60 (2) 204-211. (2003) doi:10.1001/archpsyc.60.2.204 http://dx.doi.org/10.1001/archpsyc.60.2.204
124. Valera, E. M., Faraone, S. V. et al. 'Functional neuroanatomy of working memory in adults with attention-deficit/hyperactivity disorder', Biological Psychiatry, 57 (5) 439-447. (2005) doi:10.1016/j.biopsych.2004.11.034 http://dx.doi.org/10.1016/j.biopsych.2004.11.034
125. van den Hoofdakker, B. J., van der Veen-Mulders, L. et al. 'Effectiveness of behavioral parent training for children with ADHD in routine clinical practice: a randomized controlled study', Journal of the American Academy of Child and Adolescent Psychiatry, 46 (10) 1263-1271. (2007) doi:10.1097/chi.0b013e3181354bc2 http://dx.doi.org/10.1097/chi.0b013e3181354bc2
126. Vitiello, B.'Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder', Journal of Child and Adolescent Psychopharmacology, 11 (1) 25-34. (2001) doi:10.1089/104454601750143384 http://dx.doi.org/10.1089/104454601750143384
127. Weiss, M., Hechtman, L.'A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults', Journal of Clinical Psychiatry, 67 (4) 611-619. (2006) doi:10.4088/JCP.v67n0412 http://dx.doi.org/10.4088/JCP.v67n0412
128. Wilens, T.'Mechanism of action of agents used in ADHD', Journal of Clinical Psychiatry, 67 (Suppl 8) 32-37. (2006)
129. Wilens, T., Biederman, J. et al. 'Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD', American Journal on Addictions, 7 156-163. (1998)
130. Wilens, T., Biederman, J. et al. 'Can adults with attention-deficit hyperactivity disorder be distinguished from those with comorbid bipolar disorder: findings from a sample of clinically referred adults', Biological Psychiatry, 54 (1) 1-8. (2003) doi:10.1016/S0006-3223(02)01666-9 http://dx.doi.org/10.1016/S0006-3223%2802%2901666-9
131. Wilens, T. E., Adler, L. A., Weiss, M. D., et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders Drug Alcohol Depend. Jul 1;96 (1-2): 145-154. 2008
132. Wilens, T., Biederman, J.'Alcohol, drugs, and attention-deficit/hyperactivity disorder: a model for the study of addictions in youth', Journal of Psychopharmacology, 20 (4) 580-588. (2006) doi:10.1177/0269881105058776 http://dx.doi.org/10.1177/0269881105058776
133. Wilens, T., Biederman, J. et al. 'Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD', Journal of Clinical Psychiatry, 70 (11) 1557-1562. (2009) doi:10.4088/JCP.08m04785pur http://dx.doi.org/10.4088/JCP.08m04785pur
134. Wilens, T., Faraone, S. et al. 'Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A metaanalytic review of the literature', Pediatrics, 11 (1) 179-185. (2003) doi:10.1542/peds.111.1.179 http://dx.doi.org/10.1542/peds.111.1.179
135. Wilens, T., Haight, B. R. et al. 'Bupropion XL in adults with ADHD: a randomized, placebo-controlled study', Biological Psychiatry, 57 (7) 793-801. (2005) doi:10.1016/j.biopsych.2005.01.027 http://dx.doi.org/10.1016/j.biopsych.2005.01.027
136. Wilens, T., Prince, J. et al. 'An open trial of bupropion for the treatment of adults with attention deficit hyperactivity disorder and bipolar disorder', Biological Psychiatry, 54 (1) 9-16. (2003) doi:10.1016/S0006-3223(02)01664-5 http://dx.doi.org/10.1016/S0006-3223%2802%2901664-5
137. Wilens, T., Zusman, R. M. et al. 'An open-label study of the tolerability of mixed amphetamine salts in adults with ADHD and treated primary essential hypertension', Journal of Clinical Psychiatry, 67 (5) 696-702. (2006) doi:10.4088/JCP.v67n0502 http://dx.doi.org/10.4088/JCP.v67n0502
138. Wilens, T. E., Hammerness, P. et al. 'An Open Study of Adjunct OROS-Methylphenidate in Children and Adolescents who are a tomoxetine Partial Responders: I. Effectiveness', J Child Adolesc Psychopharmacol, 19 (5) 485-492. (2009) doi:10.1089/cap.2008.0125 http://dx.doi.org/10.1089/cap.2008.0125
139. Wilens, T. E., Adamson, J. et al. 'Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents', Archives of Pediatric and Adolescent Medicine, 162 (10) 916-921. (2008) doi:10.1001/archpedi.162.10.916 http://dx.doi.org/10.1001/archpedi.162.10.916
140. Wilens, T. E., Adler, L. A. et al. 'Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature', Journal of the American Academy of Child and Adolescent Psychiatry, 47 (1) 21-31. (2008) doi:10.1097/chi.0b013e31815a56f1 http://dx.doi.org/10.1097/chi.0b013e31815a56f1
141. Wilens, T. E., Gignac, M. et al. 'Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications', Journal of the American Academy of Child and Adolescent Psychiatry, 45 (4) 408-414. (2006) doi:10.1097/01.chi.0000199027.68828.b3 http://dx.doi.org/10.1097/01.chi.0000199027.68828.b3
142. Wilens, T. E., Spencer, T.'The stimulants revisited', Child and Adolescent Psychiatric Clinics of North America, 9 573-603. (2000)
143. Wilens, T. E., Spencer, T. J. et al. 'Combining methylphenidate and clonidine: a clinically sound medication option', Journal of the American Academy of Child and Adolescent Psychiatry, 38 (5) 614-619; (1999) discussion 619-622.doi:10.1097/00004583-199905000-00025 http://dx.doi.org/10.1097/00004583-199905000-00025
144. Wilens, T. E., Spencer, T. J. et al. 'A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults', American Journal of Psychiatry, 158 (2) 282-288. (2001) doi:10.1176/appi.ajp.158.2.282 http://dx.doi.org/10.1176/appi.ajp.158.2.282
145. Wilens, T. E., Vitulano, M. et al. 'Cigarette smoking associated with attention deficit hyperactivity disorder', Journal of Pediatrics, 153 (3) 414-419. (2008) doi:10.1016/j.jpeds.2008.04.030 http://dx.doi.org/10.1016/j.jpeds.2008.04.030
146. Wilens, T. E., Adler, L. A., Weiss, M. D., et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders Drug Alcohol Depend. Jul 1;96 (1-2) 145-154. 2008
147. Winokur, G., Coryell, W. et al. 'Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression)' American Journal of Psychiatry, 150 (8) 1176-1181. (1993)
148. Wozniak, J., Biederman, J. et al. 'Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children' Journal of the American Academy of Child and Adolescent Psychiatry, 34 867-876. (1995) doi:10.1097/00004583-199507000-00010 http://dx.doi.org/10.1097/00004583-199507000-00010